Concepedia

Kun He

KH

Statistics

Publications

46

Citations

4.2K

H-Index

32

Active since

2007

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Affiliated Hospital of Southwest Medical University

Southwest Medical University

Sun Yat-sen University

Kun He is an author at Center for Drug Evaluation and Research specializing in medicine, oncology, and pharmacology.

Publications per year

2007–2024

46

Publications

46

FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

Dickran Kazandjian, Daniel L. Suzman, Gideon M. Blumenthal et al. · The Oncologist · 2016 · 478 citations · Full text

Medicine, Oncology, Pharmacology +12

FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1

Joohee Sul, Gideon M. Blumenthal, Xiaoping Jiang et al. · The Oncologist · 2016 · 367 citations · Full text

Medicine, Oncology, Pharmacology +17

FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond

Lee H. Pai-Scherf, Gideon M. Blumenthal, Hongshan Li et al. · The Oncologist · 2017 · 292 citations · Full text

Medicine, Oncology, Pharmacology +16

FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements

Dickran Kazandjian, Gideon M. Blumenthal, Huanyu Chen et al. · The Oncologist · 2014 · 289 citations · Full text

Medicine, Oncology, Pharmacology +12

Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Kun He et al. · Clinical Cancer Research · 2007 · 262 citations · Full text

Medicine, Hematology, Oncology +16

1–5 of 46